Consolidated Income Statement

Sales

2,795.5

2,743.9

5,409.4

5,404.3

Royalty, license and commission income

67.6

97.2

118.5

197.3

Total revenues

2,863.1

2,841.1

5,527.9

5,601.6

Cost of sales

–828.6

–768.0

–1,565.1

–1,492.0

Gross profit

2,034.5

2,073.1

3,962.8

4,109.6

Marketing and selling expenses

–601.5

–616.3

–1,151.0

–1,184.6

Royalty, license and commission expenses

–139.1

–156.5

–275.4

–292.8

Administration expenses

–151.0

–137.5

–283.3

–270.2

Other operating expenses and income

–110.4

–114.5

–177.2

–298.5

Research and development costs

–394.1

–373.5

–773.0

–779.7

Amortization of intangible assets

–197.4

–209.4

–393.6

–419.0

Operating result (EBIT)

441.0

465.4

909.3

864.8

Financial result

–50.2

–48.5

–84.9

–107.2

Profit before income tax

390.8

416.9

824.4

757.6

Income tax

–84.8

–100.8

–191.0

–172.5

Profit after tax

306.0

316.1

633.4

585.1

of which attributable to Merck KGaA shareholders (net income)

303.3

316.0

628.5

582.0

of which attributable to non-controlling interests

2.7

0.1

4.9

3.1

basic¹

0.70

0.73

1.45

1.34

diluted¹

0.70

0.73

1.45

1.34